Adora Fertility clinics in Australia adopting Folliscan AI technology to help patients

Artificial intelligence is being used for the first time in IVF treatment in Australia, making it quicker and less intrusive for patients. See how it works.

Adrienne Tam

2 min read

July 2, 2025 - 12:48PM

National News Network

Exclusive: Artificial intelligence is being used for the first time in IVF treatment in Australia, making it quicker and less intrusive for patients.

Developed by deeptech innovator MIM Fertility, the technology known as Folliscan uses new AI tech on the interface of a sonography machine to measure patients’ follicles to determine when they’re ready to have their eggs collected during treatment, instead of manual measuring methods which take longer.

This reduces traditional follicle scan times from 15 minutes to just a few minutes.

Adora Fertility has become the first clinic in Australia to introduce the AI follicle scanning tech into the monitoring stage of IVF treatment in Australia, an advancement typically limited to embryo grading until now.

“Introducing Folliscan is a significant breakthrough for us and for our patients — it reduces the scan time to just a few minutes, giving us more time to focus on the patient experience, all without compromising clinical results,” Vanessa Ferguson, Adora Fertility’s CEO, said.

Adora’s Perth and Brisbane clinics are already using the AI ultrasound technology, with a national rollout now underway.

Adora Fertility’s National Nurse and Operations Manager Jennifer Griffiths said when a patient has IVF, they are required to have multiple monitoring scans during their stimulation phase.

National Nurse and Operations Manager Jennifer Griffiths at Adora Fertility, using the Folliscan machine. Picture: Supplied

“The purpose is to understand what the patient’s response has been to their medication. So we are counting how many follicles are growing on each ovary, and we’re measuring the size of them,” she said.

“And we need to do that multiple times, usually every second or third day after they’ve been using their meds for about five days or so.”

Traditionally, follicle tracking requires manual measurement of each follicle using ultrasound, which involves multiple frozen images and manual inputs.

“It can be a lengthy process to go through and measure each and every follicle, while a patient has got a transvaginal probe in situ. It can be uncomfortable, especially as the patient starts going through their cycle, as their ovaries become quite enlarged and it can be a little bit tender,” Ms Griffiths said.

The Folliscan AI technology showing the different follicles being identified in different colours. Picture: Supplied

“Whereas with the Folliscan, what we do is pop the probe in, find the ovary, and it just requires a minimum of a two-second pan of the ovary, and then that video drops into the app. “Then the AI technology essentially maps over and measures the follicle at its biggest, and basically does it all for you.”

Ms Griffiths stresses that the manual or human component of the scan is still needed despite the AI tech having 97 per cent accuracy.

“We don’t just rely on the AI doing the scan. Whoever is scanning actually then goes back and reviews what the AI has done,” she explained.

“We’re using Folliscan as a tool to support us, and I suppose, to improve the outcome of the scan, but we’re still heavily involved. We don’t just go, ‘Oh, there’s the video. AI’s done it’, and move on.”

MIM Fertility CEO Ula Sankowska said she is “thrilled” to see Folliscan introduced in Australia.

“Adora Fertility’s adoption of Folliscan is an important step towards modernising fertility treatments and making them more efficient and accessible,” Ms Sanknowska said.